EDITAS MEDICINE, INC. Repayments of Notes Payable
EDITAS MEDICINE, INC. (EDIT) reported Repayments of Notes Payable of $600.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2020-02-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfNotesPayable · last filed 2020-02-26
- EDITAS MEDICINE, INC. repayments of notes payable for the quarter ending 2017-12-31 was $0.00.
- EDITAS MEDICINE, INC. repayments of notes payable for fiscal 2017 was $600.00K.
| Period end | Repayments of Notes Payable 3 month | Repayments of Notes Payable 9 month | Repayments of Notes Payable 12 month |
|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $600.00K 10-K · filed 2020-02-26 | |
| 2017-09-30 | $600.00K 10-Q · filed 2018-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |